ft.com | UK Follow Novo investors call for dealmaking and new drugs Ozempic maker is under pressure to diversify as it prepares to face shareholders on Monday https://www.ft.com/content/e560fd8c-5cc2-4743-90eb-eab71b899ce6?syn-25a6b1a6=1 ft.com
